Is the NAD+ IV drip worth it? What longevity clinics are selling versus what the evidence shows

TL;DR

NAD+ (nicotinamide adenine dinucleotide) is a real coenzyme that declines with age, and boosting it does interesting things in mice. But the IV drip specifically — the thing clinics are selling for hundreds of dollars a session — has almost no human trial data behind it. What data exists comes from oral precursors like NMN and NR, not intravenous NAD+ itself, and even those trials show modest, inconsistent effects on energy or metabolic markers, not reversed aging. If you're paying for an "anti-aging" IV drip, you're mostly paying for the infusion experience and the story, not a proven longevity intervention.

What is NAD+ and why do clinics say it matters?

NAD+ is a coenzyme every cell needs to run mitochondrial energy production and DNA repair. It's genuinely central to metabolism — that part isn't marketing. Levels do measurably drop with age; a widely cited paper by Imai and Guarente, "NAD+ and sirtuins in aging and disease" (Trends in Cell Biology, 2014), lays out the biology of why researchers got excited about this in the first place. The leap clinics make is from "NAD+ declines with age" to "so infusing it will slow your aging," which is a much bigger claim than the basic science supports.

What does the human research actually show?

Here's the catch: almost none of the human research is on IV NAD+. Most of the clinical trials use oral precursors — nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) — because NAD+ itself is poorly absorbed orally and hard to study cleanly even by infusion.

A 2018 randomized trial by Martens et al., "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults" (Nature Communications), found that NR supplementation did raise NAD+ levels in blood, and was safe over six weeks — but it didn't significantly improve insulin sensitivity, blood pressure, or other markers of "healthy aging" in that study. A separate small trial, Airhart et al. 2017 (published in PLOS ONE), tracked NR pharmacokinetics in humans and confirmed it's absorbed and raises NAD+ metabolites, but again didn't test functional outcomes like energy or cognition in any rigorous way.

As for the IV route specifically: there is essentially no published randomized controlled trial testing intravenous NAD+ infusions against placebo for energy, cognition, or aging biomarkers in healthy adults. Most of what's circulating is case reports, addiction-treatment literature (NAD+ IVs were originally popularized in some substance-withdrawal clinics), and clinic-funded testimonials. That's a meaningfully different evidence tier than a peer-reviewed RCT.

Why does the drip feel like it works?

People often report feeling more alert or clear-headed during or right after an NAD+ infusion. Some of that plausibly involves the coenzyme's real role in cellular energy metabolism. But a two-hour IV drip also involves being hydrated, sitting still, off your phone, in a calm clinical setting — all of which independently make people feel better temporarily. Without a placebo-controlled comparison (saline drip, same setting, same duration), it's genuinely hard to separate "NAD+ did this" from "lying down and getting fluids did this."

Are there risks or downsides?

NAD+ infusions are generally described as well-tolerated, but they're not nothing: some people report flushing, nausea, chest tightness, or cramping during infusion, especially if it's pushed too fast. Because it's typically administered in medical-spa or wellness-clinic settings rather than hospitals, the IV itself carries the usual small risks of any infusion — infection at the site, vein irritation — and the product isn't FDA-approved as a drug for anti-aging use, so purity and dosing aren't standardized the way a prescription drug's would be. The bigger risk is financial and opportunity cost: repeated $300–$1,000 sessions add up fast for a benefit that's currently more assumed than demonstrated.

How does IV NAD+ compare to oral NMN or NR supplements?

Oral precursors are cheaper (often $30–$60/month), have more actual human trial data behind them (even if that data is modest), and can be taken indefinitely without a clinic visit. IV NAD+ theoretically bypasses the absorption limits of the oral route, which sounds like an advantage — but since nobody has run the head-to-head trial showing IV NAD+ produces better outcomes than oral precursors in healthy adults, that theoretical advantage hasn't been demonstrated to translate into a real one. If you're going to spend money chasing this pathway, the oral-precursor trials are the closest thing to an evidence base you actually have.

FAQ

Q: Is NAD+ IV therapy FDA-approved for anti-aging?
A: No. NAD+ is not FDA-approved as a drug for anti-aging, energy, or longevity indications. Clinics offering it are operating outside an approved-indication framework, similar to many other IV "wellness" infusions.

Q: Will an NAD+ drip actually slow aging?
A: There's no human trial showing this. The aging-biology rationale is real and interesting, but it hasn't been tested with IV NAD+ in a rigorous, placebo-controlled way in healthy people.

Q: Is oral NMN or NR a better bet than the IV drip?
A: It's cheaper and has more (though still limited) human data, like the Martens et al. 2018 trial. "Better bet" is relative — neither has strong evidence for anti-aging outcomes yet, but oral precursors let you test the water without a four-figure monthly clinic bill.

Q: Why do people feel energized right after the infusion?
A: Possibly the NAD+ itself, possibly the hydration and rest during a slow IV session, possibly a placebo response to an expensive, ritualized treatment. No published trial has isolated which factor is doing the work.

Sources

• Martens, C.R. et al. "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults." Nature Communications, 2018.
• Airhart, S.E. et al. "An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers." PLOS ONE, 2017.
• Imai, S. and Guarente, L. "NAD+ and sirtuins in aging and disease." Trends in Cell Biology, 2014.

Medical Disclaimer

This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions or using any treatments discussed herein. Results vary by individual.